Afleveringen

  • In this special Halloween episode of Beyond the Drip, our co-hosts Jon Love, Pamela McIntyre, Brandon Carpenter and Brian O'Sullivan reminisce on some of the most spine-tingling stories in the infusion market. Together, they explore the industry’s “scariest stories”—from unsettling trends and operational risks to hidden threats few are talking about but are bound to impact the industry. These tales from the infusion world reveal the looming challenges and emerging risks facing providers today and, more importantly, how they’re preparing for what lies ahead. In this episode, the hosts unpack:
    The demand from med spas and wellness clinics that is stretching critical IV supplies, leaving hospitals and infusion providers vulnerable to delays in elective surgeries and patient care. The recent RAF score adjustments and plan changes, which are cutting provider revenue, causing insurers to exit certain regions and fueling concerns of a single-payer system that limits senior access to care. The fact that some states are dominated by a few insurers, causing costs to rise and dwindling patient choice, sparking calls for more competition in the market. The escalation of cyberattacks, with breaches underscoring the value of healthcare data. Ransomware strains providers’ resources, pushing them to strengthen system defenses. Staffing shortages, product mix-ups and data issues creating daily pressures for providers, intensifying the need for efficient, risk-aware operations. Listen to this episode of Beyond the Drip to hear more about these frightening trends and what our industry experts are doing to navigate these murky waters. Their insights offer a roadmap for infusion and pharmacy providers who want to stay ahead of the curve in an increasingly unpredictable landscape.

  • Welcome to “Beyond the Drip,” where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired.

    In episode four, we have a special guest, Randy Broyles, Chief Strategy Officer at CSI Pharmacy. An in-depth exploration of the career and insights of Randy Broyles in the Infusion industry. A history of navigating growth, challenges and M&A activity and what we can learn form it for the future.

  • Zijn er afleveringen die ontbreken?

    Klik hier om de feed te vernieuwen.

  • Welcome to “Beyond the Drip,” where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired.

    In episode three, our panel explores a pressing issue in both the tech and healthcare sectors: monopolies. The episode begins with a conversation about the Department of Justice’s (DOJ) landmark decision to bring an antitrust lawsuit against Google, highlighting its dominance in the market. The discussion soon draws a parallel between Google’s market dominance and the growing monopolies within the healthcare industry, particularly among payers.

  • In this episode of Beyond the Drip, the hosts discuss the Wild West of infusion therapy. They explore the reasons behind the growth of infusion therapy, including the consumer-centric approach and the demand for quality healthcare. They also discuss the challenges and risks involved in entering the infusion therapy market, such as the lack of common language and the need for expertise. The hosts highlight the importance of understanding the payer landscape and the operational hurdles of staffing, logistics, and training. They also touch on the influx of private equity and independent pharmacies into the market. The conversation explores the challenges and opportunities in the infusion therapy industry, particularly in the emerging field of ambulatory infusion centers (AICs). The speakers discuss the shortage of IV fluids due to non-medical use, the merging of the infusion world, and the need for proper training and patient safety in IV bars. They also touch on the importance of compliance and regulation, cautionary tales of failed AICs, and the future of the industry, including consolidation and the potential for new entrants.

    Keywords
    infusion therapy, Wild West, growth, consumer-centric, challenges, risks, payer landscape, operational hurdles, staffing, logistics, training, private equity, independent pharmacies, infusion therapy, ambulatory infusion centers, IV fluids, IV bars, training, patient safety, compliance, regulation, cautionary tales, consolidation, new entrants
    Takeaways
    Infusion therapy is experiencing significant growth due to its consumer-centric approach and the demand for quality healthcare.Entering the infusion therapy market comes with challenges and risks, including the lack of a common language and the need for expertise.Understanding the payer landscape is crucial for success in the infusion therapy market.Operational hurdles such as staffing, logistics, and training are important considerations for infusion therapy centers.The market is seeing an influx of private equity and independent pharmacies, which adds to the competition and complexity of the industry. There is a shortage of IV fluids due to non-medical use, which is affecting the availability of products for medically ill patients.The infusion world is merging, with more IV bars potentially transitioning to treat medically ill patients.Proper training and understanding of patient care in the infusion therapy industry is crucial, as the process of placing an IV and administering medications is different for medically ill patients.There have been cases of unlicensed personnel treating patients in IV clinics and med spas, leading to serious complications and even deaths.The industry needs to focus on patient safety, education, and compliance to prevent harm and maintain quality outcomes.Payers should prioritize standards that address quality outcomes and staff training in AICs, rather than solely accrediting the pharmacy function.Opening an AIC requires careful consideration of referral plans, payer strategies, and contracts to ensure financial viability and success.Consolidation in the infusion therapy industry, similar to what happened in home infusion, may occur in the future.The future of the industry may involve healthcare organizations offering a range of infusion services, including home infusion, specialty infusion, AICs, and AISs.The success of AICs lies in high service, high touch, patient-centric care, and convenience.
    Titles
    Understanding the Payer Landscape in Infusion TherapyNavigating the Uncharted Territory of Infusion Therapy Cautionary Tales and Lessons Learned in the AIC SpaceThe Merging World of Infusion Therapy and the Rise of AICs
    Sound Bites
    "I saw enough.""Beyond the Drip is a comprehensive podcast around the infusion providers, infusion therapies and everything.""This episode is called the Wild West of Infusion.""There is a shortage on IV fluids. There's a nationwide problem getting products for people who are sick because of the non-medical use.""I'm worried about consumers who have that low expectation of quality that any nurse can stick a needle in their arm and give them B12 or whatever it is.""Did you know as long as the medical director is within their confines, a physician can supervise anyone to administer IVs?"
    Chapters00:00The Wild West of Infusion
    06:26Uncharted Territory
    09:19High Potential Rewards
    10:47Significant Risks
    15:59The Importance of Experts and a Common Language
    17:17Understanding the Payer Landscape
    17:43Considering the Competitive Landscape
    18:13The Wild West of Infusion Therapy
    23:09Training and Compliance: Ensuring Patient Safety
    28:12Patient Safety and the Potential Risks
    33:20Consolidation: The Future of the Industry
    36:53Success Stories and Cautionary Tales
    42:18The Future of Infusion Therapy: Risks and Opportunities

  • Beyond the Drip is a podcast about home infusion, specialty infusion, AIC, and all things infusion. The hosts, John Love, Brandon Carpenter, Pam McIntyre, and Brian O'Sullivan, discuss the operations, technology, services, and payers in the infusion industry.

    The first guest on the podcast is Reese Norris, co-founder and COO of WeInfuse Software. Reese shares the story of WeInfuse, from its beginnings as an infusion operator to the development of their proprietary software. The conversation also touches on the importance of a great team, the value of customer service, and the challenges of transitioning from on-prem to cloud-based software. WeInfuse is expanding its software suite to include oncology and pharmacy modules, allowing them to target the home infusion pharmacy, specialty pharmacy, and oncology markets. They are developing an RxToolkit specifically for oncology and believe they can build a better billing and claims system for the infusion industry. The reimbursement landscape is dynamic and varies by region, making it challenging for providers to navigate.

    Building relationships with payers is important, but it can be difficult due to the complexity of the industry. WeInfuse aims to be the go-to solution for medication delivery and wants to be at the center of providers' technology ecosystems.

    Keywords: podcast, home infusion, specialty infusion, AIC, infusion industry, operations, technology, services, payers, WeInfuse Software, team, customer service, on-prem, cloud-based software, WeInfuse, software suite, oncology, pharmacy, home infusion pharmacy, specialty pharmacy, oncology market, RxToolkit, billing and claims system, reimbursement landscape, payers, medication delivery, technology ecosystem
    Takeaways
    Beyond the Drip is a podcast that explores various aspects of the infusion industry, including operations, technology, services, and payers.The first guest on the podcast is Reese Norris, co-founder and COO of WeInfuse Software, who shares the story of WeInfuse and its journey from being an infusion operator to developing their own software.WeInfuse focuses on providing excellent customer service and building a great team to drive their success.The conversation also highlights the challenges and benefits of transitioning from on-prem to cloud-based software. WeInfuse is expanding its software suite to include oncology and pharmacy modules, allowing them to target the home infusion pharmacy, specialty pharmacy, and oncology markets.They are developing an RxToolkit specifically for oncology and believe they can build a better billing and claims system for the infusion industry.The reimbursement landscape is dynamic and varies by region, making it challenging for providers to navigate.Building relationships with payers is important, but it can be difficult due to the complexity of the industry.WeInfuse aims to be the go-to solution for medication delivery and wants to be at the center of providers' technology ecosystems.
    Titles
    Exploring the Infusion Industry: Beyond the Drip PodcastThe Journey of WeInfuse: From Operator to Software Developer Navigating the Dynamic Reimbursement LandscapeExpanding into the Oncology and Pharmacy Markets

    Chapters00:00Introduction to Beyond the Drip Podcast
    03:34The Journey of WeInfuse
    09:44The Importance of Customer Service and Building a Great Team
    19:10The Future of WeInfuse: Home Infusion and Integration
    23:30Solving Pain Points in the Infusion Industry
    26:47Transitioning to Cloud-Based Software
    29:08Ensuring Security in Healthcare Software
    30:08Expanding into the Oncology and Pharmacy Markets
    34:11Building a Better Billing and Claims System for Infusion
    35:11Navigating the Dynamic Reimbursement Landscape
    37:00Challenges of Building Relationships with Payers
    38:24Becoming the Go-To Solution for Medication Delivery